Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-17 4:11 pm Sale | 2023-07-13 | 13D | Galecto, Inc. GLTO | ORBIMED ADVISORS LLC | 98,226 9.600% | -9,641 (-8.94%) | Filing History |
| 2023-06-29 4:36 pm Purchase | 2023-06-27 | 13D | Passage Bio, Inc. PASG | ORBIMED ADVISORS LLC | 401,700 14.700% | 59,629 (+17.43%) | Filing History |
| 2023-06-29 4:30 pm Purchase | 2023-06-27 | 13D | Adicet Bio, Inc. ACET | ORBIMED ADVISORS LLC | 6,647,598 15.500% | 6,647,598 (New Position) | Filing History |
| 2023-06-21 4:53 pm Purchase | 2023-06-16 | 13D | Disc Medicine, Inc. IRON | ORBIMED ADVISORS LLC | 2,269,637 10.200% | 108,696 (+5.03%) | Filing History |
| 2023-05-24 4:52 pm Sale | 2023-05-21 | 13D | VectivBio Holding AG VECT | ORBIMED ADVISORS LLC | 5,156,561 7.700% | -1,557,000 (-23.19%) | Filing History |
| 2023-05-24 4:47 pm Purchase | 2023-05-22 | 13D | Prelude Therapeutics Incorporated PRLD | ORBIMED ADVISORS LLC | 15,716,642 28.600% | 869,565 (+5.86%) | Filing History |
| 2023-05-17 4:46 pm Sale | 2023-05-15 | 13D | SpringWorks Therapeutics, Inc. SWTX | ORBIMED ADVISORS LLC | 4,178,588 6.700% | -806,412 (-16.18%) | Filing History |
| 2023-05-16 4:28 pm Unchanged | 2023-05-11 | 13D | Fusion Pharmaceuticals Inc. FUSN | ORBIMED ADVISORS LLC | 2,930,670 4.600% | 0 (Unchanged) | Filing History |
| 2023-05-16 4:25 pm Sale | 2023-05-15 | 13D | 89bio, Inc. ETNB | ORBIMED ADVISORS LLC | 3,777,778 4.800% | -482,913 (-11.33%) | Filing History |
| 2023-05-08 5:01 pm Purchase | 2023-05-04 | 13D | Kinnate Biopharma Inc. KNTE | ORBIMED ADVISORS LLC | 7,559,729 16.200% | 1,460,932 (+23.95%) | Filing History |
| 2023-05-05 11:14 am Unchanged | 2023-05-01 | 13D | Xtant Medical Holdings, Inc. XTNT | ORBIMED ADVISORS LLC | 73,114,592 67.100% | 0 (Unchanged) | Filing History |
| 2023-05-02 7:28 pm Purchase | 2023-04-28 | 13D | Kinnate Biopharma Inc. KNTE | ORBIMED ADVISORS LLC | 6,098,797 13.100% | 1,405,168 (+29.94%) | Filing History |
| 2023-04-21 5:03 pm Sale | 2023-04-19 | 13D | TELA Bio, Inc. TELA | ORBIMED ADVISORS LLC | 2,866,267 11.900% | -192,000 (-6.28%) | Filing History |
| 2023-04-11 7:10 pm Purchase | 2023-03-29 | 13D | Apollomics, Inc. APLM | ORBIMED ADVISORS LLC | 6,626 10.300% | 6,626 (New Position) | Filing History |
| 2023-04-07 4:38 pm Sale | 2023-04-05 | 13D | Galecto, Inc. GLTO | ORBIMED ADVISORS LLC | 107,866 10.500% | -2,992 (-2.70%) | Filing History |
| 2023-03-31 4:48 pm Purchase | 2023-03-29 | 13D | Gracell Biotechnologies Inc. GRCL | ORBIMED ADVISORS LLC | 7,583,576 11.200% | 1,612,904 (+27.01%) | Filing History |
| 2023-03-29 5:24 pm Unchanged | 2023-03-27 | 13D | Terns Pharmaceuticals, Inc. TERN | ORBIMED ADVISORS LLC | 7,619,135 13.400% | 0 (Unchanged) | Filing History |
| 2023-03-24 4:57 pm Purchase | 2023-03-22 | 13D | CalciMedica, Inc. CALC | ORBIMED ADVISORS LLC | 297,380 5.400% | 297,380 (New Position) | Filing History |
| 2023-03-24 4:43 pm Sale | 2023-03-22 | 13D | 89bio, Inc. ETNB | ORBIMED ADVISORS LLC | 0 0.000% | -1,504,436 (Position Closed) | Filing History |
| 2023-03-22 4:27 pm Purchase | 2023-03-20 | 13D | CalciMedica, Inc. CALC | ORBIMED ADVISORS LLC | 297,380 18.900% | 297,380 (New Position) | Filing History |